<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p53 mutations are involved in the pathogenesis of <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Our study included patients with histopathologically classified Barrett's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and shows that p53 mutations are clinically important for curatively resected (R0) Barrett's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>It appears that the p53 mutation status is a promising parameter for the definition of risk groups after potentially curative resections </plain></SENT>
</text></document>